These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2676087)

  • 1. The molecular biology of CML: a review.
    Leibowitz D; Young KS
    Cancer Invest; 1989; 7(2):195-203. PubMed ID: 2676087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
    Kamada N; Tanaka K; Asou H
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biology of chronic myeloid leukemia].
    Hellmann A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity of adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Schaefer-Rego K; Arlin Z; Shapiro LG; Mears JG; Leibowitz D
    Cancer Res; 1988 Feb; 48(4):866-9. PubMed ID: 2827888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
    Huang W; Cao Q; Lu Y
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
    Usui N
    Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia as a model for the genetic basis of cancer.
    Cannistra SA
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):337-57. PubMed ID: 2182595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of Bcr-Abl-induced oncogenesis.
    Gishizky ML
    Cytokines Mol Ther; 1996 Dec; 2(4):251-61. PubMed ID: 9384712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    O'Brien S; Kantarjian H; Shtalrid M; Blick M; Beran M; Talpaz M
    Hematol Pathol; 1988; 2(1):25-9. PubMed ID: 3235381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
    Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A; Outeriño J; Martín Calderín F; Benítez J
    Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [c-abl gene and bcr-abl fused gene in Ph1-positive leukemias].
    Okabe M; Kunieda Y; Miyazaki T; Kakinuma M
    Nihon Rinsho; 1990 Aug; 48(8):89-97. PubMed ID: 2255098
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rearrangement and expression of bcr-abl genes in CML and ALL].
    Kunieda Y; Okabe M
    Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.